US Earnings Financial Results SEC Filings — July 09, 2026

09-07-2026

Huineng Technology Corp (HNIT) reported a dramatic turnaround for the six months ended May 31, 2026, with revenue surging to $28,000 from $4,600 in the prior-year period, driven by new development service revenue of $12,000 and a sharp increase in design service revenue to $15,000. The company swung to a net income of $10,067 from a net loss of ($21,036) in the prior period, largely due to a significant reduction in general and administrative expenses. However, cash and cash equivalents declined to $504 from $758 at the start of the period, and the company continues to operate with negative working capital and an accumulated deficit of ($69,645).

• · The company had negative working capital of $10,662 in current liabilities vs $13,487 in current assets as of May 31, 2026.
• · Cash used in operating activities was ($254) for the six months ended May 31, 2026, compared to ($1,584) in the prior period.
• · Accounts receivable increased from $0 to $5,000 during the six-month period.
• · The company had no income tax expense for any period reported.
• · Net income per share (basic and diluted) was $0.0002 for the six months ended May 31, 2026, compared to a loss of ($0.0008) per share in the prior period.
• · The weighted average number of shares outstanding increased to 44,545,000 for the six months ended May 31, 2026 from 26,856,475 in the prior period.

09-07-2026

PepsiCo reported strong financial results for the 12 and 24 weeks ended June 13, 2026, with net revenue increasing 6.4% to $24.2B (Q2) and 7.3% to $43.6B (H1) year-over-year. Net income attributable to PepsiCo surged to $2.98B (Q2) and $5.31B (H1), compared to $1.26B and $3.10B in the prior-year periods, which included a $1.86B impairment charge. However, operating cash flow improved significantly to $2.37B (H1) from $1.0B, while the company continued to return capital via dividends ($3.91B) and share repurchases ($479M).

• · Segment operating profit for Q2: PFNA $1,342M, PBNA $1,053M, IB Franchise $637M, EMEA $751M, LatAm Foods $616M, Asia Pacific Foods $127M.
• · Corporate unallocated expenses were $503M in Q2.
• · Total debt (short-term + long-term) increased to $53.2B as of June 13, 2026 from $49.2B at year-end 2025.
• · Cash dividends declared in H1 2026 were $3.98B, up from $3.82B in H1 2025.
• · Share repurchases in H1 2026 were $479M, slightly down from $494M in H1 2025.
• · Capital spending in H1 2026 was $1.27B, down from $1.51B in H1 2025.
• · Net cash used for financing activities was $130M in H1 2026, compared to $1.87B provided in H1 2025, primarily due to higher debt repayments and lower net short-term borrowings.
• · Cash and cash equivalents and restricted cash ended at $10.3B, up from $7.7B a year ago.
• · Goodwill increased to $19.1B from $18.9B at year-end 2025.
• · Accumulated other comprehensive loss improved to $(14.3)B from $(15.0)B at year-end 2025.

09-07-2026

EACO Corp reported strong financial results for the third quarter and first nine months of fiscal 2026. Net sales for the quarter ended May 31, 2026 increased 27.8% YoY to $142,350, while net income attributable to common shareholders rose 42.6% to $13,546. For the nine-month period, net sales grew 21.5% to $371,139 and net income attributable to common shareholders increased 41.2% to $32,625. However, operating cash flow declined sharply to $4,532 from $9,404 in the prior-year period, and cash and cash equivalents fell to $758 from $7,270 a year ago, reflecting significant working capital investment and capital expenditures.

• · Gross margin improved to 31.2% of net sales in Q3 FY2026 from 30.6% in Q3 FY2025.
• · SG&A expenses increased 22.3% YoY to $26,445 but declined as a percentage of net sales to 18.6% from 19.4%.
• · Net gain on trading securities was $251 in Q3 FY2026 vs $277 in Q3 FY2025.
• · Total assets grew to $268,089 as of May 31, 2026 from $230,153 as of August 31, 2025.
• · Inventory increased to $94,846 from $83,980 at August 31, 2025.
• · Trade accounts receivable rose to $72,173 from $65,863 at August 31, 2025.
• · Long-term debt was fully repaid, with current portion of long-term debt at $4,113 and no non-current long-term debt as of May 31, 2026.
• · Cash paid for income taxes surged to $23,493 for the nine months ended May 31, 2026 from $9,213 in the prior-year period.
• · Weighted average remaining lease term was 3.3 years at May 31, 2026 vs 2.8 years at August 31, 2025.
• · Incremental borrowing rate for operating leases was 7.3% at May 31, 2026 vs 7.2% at August 31, 2025.

09-07-2026

WidFit Inc. filed its 10-K annual report for the year ended December 31, 2025, reporting its first-ever revenues of $1,632 (from zero in 2024) following an acquisition in December 2025. However, the company's net loss widened to $21,464 from $14,515 in 2024, and cash used in operations increased to $16,324 from $14,515. Cash and cash equivalents fell sharply to $6,568 from $22,792 at the end of 2024, indicating significant cash burn.

• · Professional fees increased to $22,500 in 2025 from $14,400 in 2024.
• · General and administrative expenses rose to $328 in 2025 from $115 in 2024.
• · The company had no income tax expense in either year due to a full valuation allowance.
• · Weighted average common shares outstanding increased slightly to 7,801,699 in 2025 from 7,800,000 in 2024.
• · Net loss per share remained $0.00 in both years.
• · Total liabilities increased marginally to $8,700 at Dec 31, 2025 from $8,500 at Dec 31, 2024.
• · The acquisition added $11,225 in accounts receivable and $1,391 in due to related party liabilities.

09-07-2026

MADE IN USA INC. reported a net loss of $2,987 for the three months ended May 31, 2026, a significant improvement from a net loss of $31,526 in the same period last year. However, the company generated zero sales revenue in the current quarter compared to $11,476 in the prior year, and ended the period with zero cash on hand. Total assets declined to $90,818 from $93,805, while accumulated deficit widened to $66,097.

• · General and administrative expenses dropped sharply from $43,002 to $2,987 YoY, driving the loss reduction.
• · The company had zero cash at both the beginning and end of the current quarter, and generated no cash from operations, investing, or financing activities.
• · Intangible assets, net, decreased from $92,555 to $90,818 due to $2,987 in amortization.
• · A related party loan of $622 remained outstanding, unchanged from the prior period.
• · The company maintained a full valuation allowance against its deferred tax assets, resulting in zero net deferred tax asset.
• · Shares outstanding increased from 6,695,000 to 17,962,640 year-over-year, indicating significant equity issuance in the past year.

09-07-2026

Barnes & Noble Education reported strong revenue growth of 6.5% to $1.715B for the 52 weeks ended May 2, 2026, driven by a 28% increase in BNC First Day sales. Net income turned positive at $16.9M vs. a loss of $65.8M in the prior year. However, comparable store sales growth slowed to 4.4% from 7.5%, and general merchandise comparable sales declined 2.1%.

• · Product sales and other increased 6.9% to $1.564B, while rental income grew 2.4% to $150.4M.
• · Operating income more than doubled from $15.9M to $36.5M, with operating margin improving from 1.0% to 2.1%.
• · Depreciation and amortization decreased 13.7% from $37.9M to $32.8M.
• · Impairment loss surged from $1.7M to $12.6M, a 634% increase.
• · Gross margin improved slightly from 21.0% to 21.4%.
• · Selling and administrative expenses as a percentage of sales decreased from 17.6% to 16.8%.
• · Total adjusted EBITDA increased 28.8% to $76.5M.
• · Textbooks comparable store sales decreased 22.9% to $82.3M from $106.7M.
• · General merchandise comparable store sales turned negative, declining 2.1% vs. +1.9% prior year.
• · New stores contributed $100.0M in sales, while closed stores reduced sales by $69.0M; comparable stores added $83.0M.
• · Spring 2026 First Day Complete enrollment rose 31% to 1,250,585 students across 232 campuses.

09-07-2026

WD-40 Company reported strong growth in its third fiscal quarter ended May 31, 2026, with net sales rising 24.4% YoY to $195.1M and net income increasing 44.0% to $30.2M. For the nine-month period, net sales grew 12.0% to $511.2M; however, net income declined 2.5% to $68.0M due to a higher effective tax rate. The company continued its aggressive share repurchase program, buying back 39,500 shares in Q3, and increased dividends. Working capital increased, and short-term borrowings rose sharply to $15.3M from $0.8M at August 31, 2025.

• · Gross profit margin increased to 56.6% in Q3 FY2026 from 56.2% in Q3 FY2025.
• · Total operating expenses as a percentage of net sales decreased to 35.9% in Q3 FY2026 from 38.7% in Q3 FY2025.
• · The company paid dividends of $1.02 per share in Q3 FY2026.
• · Inventory write-offs increased to $1.4M for 9M FY2026 from $0.7M for 9M FY2025.
• · Provision for income taxes for the nine-month period jumped to $20.0M from $4.4M, largely due to a $11.9M tax benefit release in the prior year.

09-07-2026

Simulations Plus, Inc. reported a strong turnaround for the nine months ended May 31, 2026, with net income of $8.8M compared to a net loss of $64.0M in the prior-year period, driven by the absence of a $77.2M impairment charge that had weighed on the prior year. Revenue grew 4.7% to $64.6M, led by a 14.3% increase in services revenue to $28.5M, while software revenue was essentially flat at $36.1M. The company's balance sheet strengthened with total assets of $153.0M and shareholders' equity of $139.0M, up from $131.9M and $124.8M respectively at August 31, 2025.

• · Software revenue was essentially flat for both the quarter (-0.1%) and nine-month period (-1.9%), indicating a stagnant licensing business.
• · Gross profit margin improved to 65.3% for the nine months (from 58.9% a year ago) and 69.1% for Q3 (from 64.0%).
• · Research and development expenses increased significantly: 180% in Q3 ($3.4M vs $1.2M) and 89.3% for the nine months ($9.9M vs $5.2M).
• · Sales and marketing expenses decreased 5.3% in Q3 and 6.5% for the nine months.
• · General and administrative expenses decreased 23.7% in Q3 and 20.3% for the nine months.
• · The company had no debt as of May 31, 2026, with total liabilities of $13.9M (all current and operating lease).
• · Accounts receivable increased 77% to $17.2M from $9.7M at August 31, 2025, potentially indicating slower collections.
• · Deferred revenue more than doubled to $5.3M from $2.7M, suggesting strong advance payments from customers.
• · Net cash provided by operating activities increased 54.3% to $19.4M.
• · The company invested $28.2M in short-term investments during the nine months, up from $6.5M in the prior year.
• · Capitalized software development costs were $2.3M for the nine months, slightly up from $2.1M.
• · The accumulated deficit improved to ($25.6M) from ($34.4M) at August 31, 2025.
• · Basic EPS was $0.44 for the nine months vs ($3.19) in the prior year; diluted EPS was $0.43 vs ($3.19).

09-07-2026

Nurix Therapeutics reported a net loss of $89.5 million for Q2 FY2026, nearly double the $43.5 million loss in the same quarter last year, driven by a sharp decline in total revenue to $9.0 million from $44.1 million (including a $30 million license fee in the prior year). R&D expenses rose 12% year-over-year to $87.7 million, while the company's cash and equivalents plummeted to $67.7 million from $247.0 million at November 30, 2025, after $18.0 million in net ATM proceeds. The company's accumulated deficit widened to $1.18 billion.

• · Cash flow from operations used $168.5M in the six months ended May 31, 2026, compared to $124.2M in the prior-year period.
• · Investing activities used $30.8M in the six months (vs. $97.0M provided in the prior year), driven by net purchases of marketable securities.
• · The company completed an at-the-market (ATM) financing, raising $18.0M net of issuance costs during the six-month period.
• · Total assets declined to $535.5M from $688.1M at November 30, 2025.
• · Deferred revenue (current and non-current) fell to $19.3M from $27.6M at November 30, 2025.
• · Stock-based compensation totaled $20.8M for the six months, up 8.8% from $19.1M a year ago.
• · Weighted-average diluted shares outstanding increased to 110.6 million from 83.7 million year-over-year, reflecting share issuance activity.

09-07-2026

KB Home reported a sharp decline in financial performance for the three and six months ended May 31, 2026. Total revenues fell 27.3% to $1.11B for the quarter and 25.0% to $2.19B for the six-month period, while net income dropped 74.6% to $27.3M and 72.0% to $60.8M, respectively. The company's housing gross profit margin contracted from 19.3% to 15.2% in the quarter, and all four geographic segments experienced declines in revenues and operating income, with the West Coast and Southwest segments seeing the largest drops.

• · All four geographic segments (West Coast, Southwest, Central, Southeast) experienced declines in revenues and operating income in Q2 2026 vs Q2 2025.
• · West Coast segment revenues fell from $660.2M to $511.5M (down 22.5%), and operating income dropped from $75.6M to $26.7M (down 64.7%).
• · Southwest segment revenues fell from $314.1M to $166.6M (down 47.0%), and operating income dropped from $55.4M to $18.4M (down 66.8%).
• · Central segment revenues fell from $283.0M to $205.8M (down 27.3%), and operating income dropped from $20.7M to $8.0M (down 61.4%).
• · Southeast segment revenues fell from $267.5M to $223.2M (down 16.6%), and operating income dropped from $20.2M to $11.9M (down 41.1%).
• · Housing gross profit margin decreased in all segments: West Coast from 18.3% to 14.0%, Southwest from 24.7% to 20.2%, Central from 18.3% to 15.6%, Southeast from 17.3% to 15.0%.
• · Net cash used in operating activities improved to $93.5M (from $165.9M in H1 2025), primarily due to lower inventory investment.
• · Stock repurchases decreased significantly: $126.0M in H1 2026 vs $252.3M in H1 2025.
• · Dividends paid decreased to $32.6M in H1 2026 from $36.5M in H1 2025.
• · Notes payable increased to $1.97B at May 31, 2026 from $1.69B at Nov 30, 2025, reflecting higher borrowings under the revolving credit facility.
• · Treasury stock decreased from $663.4M to $136.4M due to retirement of treasury shares.

09-07-2026

Jefferies Financial Group reported strong Q2 FY2026 results with net revenues of $2.21B, up 35% YoY from $1.63B, driven by a 53% surge in investment banking revenue to $1.21B. Net earnings attributable to common shareholders more than doubled to $226M ($1.02 diluted EPS) from $88M ($0.40). However, asset management fees declined 51% to $9.8M, and the company recorded a $41M other comprehensive loss vs. a $68M gain a year ago, largely due to instrument-specific credit risk adjustments.

• · Total assets grew 4.6% to $79.5B from $76.0B at Nov 30, 2025.
• · Shareholders' equity remained essentially flat at $10.57B.
• · The company repurchased $372M of common shares in H1 FY2026 vs. $57.6M in H1 FY2025.
• · Cash and cash equivalents increased to $14.3B from $14.0B at Nov 30, 2025.
• · Goodwill decreased to $1.73B from $1.84B, a decline of $112M.
• · Assets held for sale of $295M were recorded at May 31, 2026, with corresponding liabilities of $300M.
• · Interest expense for Q2 was $912M, up 6% YoY from $860M.
• · Compensation and benefits expense rose 39% YoY to $1.19B in Q2.
• · Net cash used in operating activities improved to -$138M from -$3.64B in H1 FY2025.
• · The company issued $4.82B in long-term debt and repaid $2.67B in H1 FY2026.

09-07-2026

Educational Development Corp reported a net loss of $1.40M for the quarter ended May 31, 2026, compared to a net loss of $1.08M in the same quarter last year, as net revenues fell 33.1% to $4.76M from $7.11M. The company's gross margin declined to $2.82M from $4.14M, though operating expenses also decreased 28.2% to $4.10M. Cash and cash equivalents increased to $1.66M from $1.12M at year-end, but total assets decreased to $52.88M from $54.31M.

• · Interest expense dropped dramatically from $504,300 to just $600 year-over-year, likely due to debt repayment.
• · Inventories decreased to $16.06M from $17.41M at year-end, a reduction of $1.35M.
• · Accounts receivable fell to $570,500 from $861,300 at February 28, 2026.
• · The company recorded an impairment loss on assets of $113,600 in Q1 FY27 vs. $0 in the prior year.
• · No dividends were paid in either period.
• · Cash paid for interest was only $600 in Q1 FY27 compared to $468,300 in Q1 FY26.

09-07-2026

Enerpac Tool Group Corp. reported net sales of $167.6M for Q3 FY2026 (three months ended May 31, 2026), up 5.6% YoY from $158.7M, and net earnings of $29.8M, up 35.2% from $22.0M. For the nine-month period, net sales rose 3.8% to $466.6M and net earnings increased 0.9% to $65.2M. However, the company's cash position declined sharply, with cash and cash equivalents falling 23.7% to $115.7M from $151.6M at fiscal year-end, driven by $81.1M in treasury share repurchases during the nine months.

• · Gross profit margin improved to 53.0% in Q3 FY2026 from 50.4% in Q3 FY2025.
• · Operating profit rose 30.6% to $41.4M in Q3 FY2026 from $31.7M.
• · Restructuring charges were $3.3M for nine months FY2026 vs $5.9M in prior period.
• · Cash provided by operating activities increased 23.6% to $69.3M for nine months FY2026.
• · Capital expenditures decreased 43.5% to $9.2M for nine months FY2026.
• · Total debt (current maturities + long-term debt) was $184.8M at May 31, 2026 vs $189.7M at Aug 31, 2025.
• · Weighted average diluted shares outstanding declined 5.2% to 51.6M in Q3 FY2026 from 54.4M.
• · Accumulated other comprehensive loss was $102.7M at May 31, 2026 vs $104.1M at Aug 31, 2025.

09-07-2026

Aircastle LTD reported total revenues of $235.5M for Q1 FY26 (three months ended May 31, 2026), down 9.4% from $259.8M in the prior-year period, primarily due to lower maintenance revenue and gains on sale. Net income declined 31.8% to $33.6M from $49.3M YoY. However, cash and cash equivalents surged 145% sequentially to $440.9M, and the company generated $97.7M in operating cash flow, though this was down 23.6% from $127.9M a year ago.

• · Lease rental revenue increased 6.3% YoY to $194.6M from $183.0M.
• · Interest expense, net rose 3.5% YoY to $71.2M from $68.8M.
• · Impairment of flight equipment decreased to $3.4M from $5.1M YoY.
• · Provision for credit losses was a benefit of $0.2M vs. an expense of $0.1M in the prior year.
• · The company paid $86.5M in common share dividends in Q1 FY26, up from $30.8M in Q1 FY25.
• · Total borrowings (secured + unsecured) increased to $5.4B from $5.25B sequentially.
• · Net cash provided by financing activities was $146.8M, up from $65.5M YoY.
• · Flight equipment acquisitions and improvements totaled $107.4M, down from $479.6M YoY.
• · Proceeds from sale of flight equipment were $113.9M, down from $226.8M YoY.
• · Retained earnings declined to $236.0M from $288.9M sequentially due to dividends exceeding net income.

09-07-2026

IIOT-OXYS, Inc. (ITOX) reported no revenue for the three months ended March 31, 2026 and 2025, with net loss widening to $226,162 from $157,211 in the prior-year period. Net loss attributable to common stockholders deepened to $393,673 from $180,313, driven by a $167,511 preferred stock dividend (up from $23,102) and a $97,220 loss on change in fair value of derivative liability (vs. a $15,764 gain in 2025). Cash and cash equivalents fell sharply to $6,838 from $26,342 at year-end 2025, while total stockholders' deficit expanded to $(3,726,485) from $(3,330,032).

• · Total operating expenses decreased to $63,589 from $92,258, primarily due to elimination of amortization and payroll expenses.
• · Professional fees increased to $56,224 from $14,585.
• · Interest expense decreased to $49,084 from $75,375.
• · Net cash used in operating activities was $59,624 vs. $56,532 in the prior year.
• · Cash provided by financing activities was $40,120 from sale of Series D Preferred Stock, down from $50,800.
• · Anti-dilutive shares dropped sharply to 18,670,141 from 791,316,043, mainly due to expiration of convertible note and stock equivalents.
• · Convertible note payable of $13,942 remains unchanged from December 31, 2025, with 10% interest and maturity October 31, 2026.

09-07-2026

Northern Technologies International Corp (NTIC) reported net sales of $24.2M for Q3 FY2026, up 12.6% YoY from $21.5M, and $69.5M for the nine-month period, up 12.3% YoY. However, the company swung to a net loss attributable to NTIC of $(263,291) in Q3 versus a profit of $121,775 a year ago, and a nine-month loss of $(60,795) versus a profit of $1.1M. Operating income declined 40.6% in Q3 to $515,330, while gross profit margin contracted to 33.6% from 38.4% in the prior-year quarter. Cash flow from operations turned negative at $(758,572) for the nine months, compared to positive $3.8M a year earlier.

• · Cost of goods sold increased 21.3% YoY in Q3 to $16.1M, outpacing sales growth.
• · Research and development expenses were relatively flat at $1.2M in Q3.
• · Interest expense rose 25.8% YoY in Q3 to $203,872.
• · The company had $11.8M drawn on its line of credit at quarter-end, up 26.1% from $9.3M at fiscal year-end.
• · Dividends paid to common stockholders were cut sharply: $0.02 per share in nine months FY2026 vs $0.15 per share in the prior year period.
• · Total assets increased 4.3% to $107.1M from $102.7M at fiscal year-end.
• · Accumulated other comprehensive loss widened to $(5.4M) from $(5.4M) at fiscal year-end.
• · Inventories increased 2.0% to $15.8M, driven by a 5.6% rise in finished goods.
• · Allowance for credit losses increased to $310,000 from $235,000 at fiscal year-end.
• · Assets held for sale of $869,407 were recorded as of May 31, 2026, with none at fiscal year-end.

09-07-2026

Byrna Technologies reported a sharp reversal from profitability to a net loss of $10.1M for Q2 FY2026 (three months ended May 31, 2026), compared to net income of $2.4M in the same quarter last year. Revenue plummeted 42.5% YoY to $16.4M, driven by a collapse in gross margin to 10.9% from 61.6% a year ago, due to a $3.6M write-down of ammunition inventory and a $4.5M impairment loss on property and equipment. For the six-month period, net loss was $9.3M versus net income of $4.1M in the prior year, with revenue down 16.9% to $45.4M. The company's cash position declined to $9.4M from $13.7M at November 30, 2025, and total assets fell 19.0% to $68.4M.

• · Gross margin collapsed to 10.9% in Q2 FY2026 from 61.6% in Q2 FY2025, driven by a $3.6M write-down of ammunition inventory and a $4.5M impairment loss on property and equipment.
• · Operating expenses increased 2.7% YoY to $14.6M in Q2 FY2026, while operating income swung from a profit of $3.3M to a loss of $12.8M.
• · Cash used in operating activities improved to $3.0M in H1 FY2026 from $9.2M in H1 FY2025, primarily due to a $6.1M decrease in accounts receivable.
• · Inventory decreased 6.9% to $30.4M from $32.7M at November 30, 2025, but inventory reserves increased by $2.2M.
• · Accounts payable and accrued liabilities fell 43.1% to $9.0M from $15.9M at November 30, 2025.
• · Deferred revenue balance dropped 32.0% to $354K from $521K at November 30, 2025, with net reductions exceeding additions.
• · The company repurchased $953K of common stock during H1 FY2026, compared to $55K in the prior year period.
• · Basic and diluted net loss per share for Q2 FY2026 was $(0.44), versus basic EPS of $0.11 and diluted EPS of $0.10 in Q2 FY2025.

09-07-2026

Simply Good Foods Co reported a net loss of $52.0M for Q3 FY2026 vs net income of $41.1M in Q3 FY2025, driven by a $82.0M impairment charge. Net sales declined 6.3% to $357.0M, with Atkins brand sales falling 24.6% to $84.6M. However, Quest brand sales grew 1.1% to $230.3M and OWYN sales increased 3.6% to $34.8M. The company also repurchased $213.2M of common stock during the first 39 weeks.

• · Total assets decreased from $2.40B to $2.06B due to impairment of intangible assets.
• · Long-term debt increased from $249.1M to $397.0M due to $150M debt issuance.
• · Stockholders' equity decreased from $1.81B to $1.42B due to net loss and share repurchases.
• · Operating cash flow for 39 weeks was $102.2M, down from $133.1M in prior year.
• · International net sales were relatively flat at $7.3M for Q3.

09-07-2026

Medinotec Inc. reported a strong Q1 FY26 with revenue increasing 24.2% YoY to $2.65M and net income nearly doubling to $222,014 (vs. $113,784). Gross profit rose 43.2% to $1.31M, driven by a 31.0% jump in distribution sales and a 86.6% surge in US internally designed/manufactured sales. However, operating income fell 34.8% to $180,872 due to a massive increase in selling expenses (up 2,211% to $503,255), and the company generated negative operating cash flow of ($176,125), though this was a significant improvement from ($759,238) a year ago. Cash declined 8.7% to $2.52M from $2.76M at year-end.

• · Total assets increased slightly to $6.99M from $6.81M at year-end.
• · Total liabilities rose to $1.13M from $1.10M.
• · Accumulated other comprehensive income fell to $500,654 from $581,463 due to a foreign currency translation loss of ($80,809).
• · The US segment reported an operating loss of ($24,008) vs. a loss of ($288,817) in the prior year, while the outside-US segment operating income dropped to $204,880 from $566,274.
• · Research and development expenses decreased 83.7% to $7,970 from $49,014.
• · Interest expense fell sharply to $6,868 from $31,925.
• · The company had no current income tax expense in Q1 FY26 vs. ($262,846) in Q1 FY25.
• · Weighted average shares used in EPS calculation were 11,755,548 (basic and diluted), up slightly from 11,733,750.
• · EPS improved to $0.02 from $0.01.